用eptinezumab治疗慢性偏头痛和药物过度使用头痛患者的偏头痛预防:一个简单的语言摘要
Amaal J Starling1, Melissa Kolbet2, Roger Cady3,4
1Mayo Clinic Arizona, Scottsdale, AZ, USA.
Pain management
|June 26, 2023
概括
使用eptinezumab的预防性治疗显著减少了慢性偏头痛和药物过量使用头痛患者的偏头痛日和发作严重程度. 许多参与者在治疗后不再符合诊断标准,这表明其有效性.
科学领域:
- 神经学 神经学
- 头痛 医学 医学 医学
背景情况:
- 慢性偏头痛和过度使用药物导致的头痛 (CM/MOH) 代表了一种使人失能且难以治疗的患者群体.
- 在PROMISE-2研究中,研究了针对这一特定群体的新型预防治疗方法.
研究的目的:
- 评估eptinezumab作为预防性治疗慢性偏头痛和药物过量使用头痛患者的疗效.
- 评估eptinezumab对偏头痛频率,严重程度和急性药物使用的影响.
主要方法:
- 在PROMISE-2研究中,参与者被诊断患有慢性偏头痛和药物过量使用头痛.
- 参与者接受了eptinezumab或安慰剂作为预防性偏头痛治疗.
- 关键结局包括每月偏头痛日数的变化,发作严重程度和急性药物消耗.
主要成果:
- 与安慰剂相比,eptinezumab治疗导致偏头痛日数显著减少.
- 接受eptinezumab的参与者经历了偏头痛发作严重程度的降低和急性药物需求的减少.
- 更多接受epinezumab治疗的参与者在慢性偏头痛和药物过量使用头痛标准中实现了缓解.
结论:
- 埃普特尼祖马布对患有慢性偏头痛和药物过量使用头痛的患者显著有益.
- 这种治疗为经常头痛需要急性药物治疗的个体提供了有价值的治疗选择.
- 这些发现表明,eptinezumab可以通过减少这些令人虚弱的头痛疾病的负担来改善生活质量.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
217
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
217
01:30Electroconvulsive Therapy
75
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
75
01:14Antiepileptic Drugs: Glutamate Antagonists
429
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
429
01:24Epilepsy and Seizures: Overview
228
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
228
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
251
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
251
01:23Antidepressant Drugs: MAOIs and Other Agents
279
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
279